Spinal Muscular Atrophy Medicine Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Spinal Muscular Atrophy Medicine Market is projected to grow from USD 980.6 million in 2020 to USD 2,085.4 million by 2028 at a CAGR of over 13% during the forecast period 2022-2028.

Spinal muscular atrophy (SMA) is a very rare genetic disorder that affects the part of the central nervous system that controls voluntary muscle movement. SMA is an autosomal recessive neurodegenerative genetic disorder characterized by atrophy and muscle weakness. It is one of the most common debilitating genetic disorders and a leading genetic cause of death among infants. It mainly affects about 1 in 10,000 people worldwide.

Market Segments

By Disease Type

• Type 1
• Type 2
• Type 3
• Type 4

By Treatment

• Gene Therapy
• Drug
• Spinraza
• RG6083 (Olesoxime)
• RG7916

Key Players

• Biogen (The U.S),
• Ionis Pharmaceuticals, Inc. (The U.S),
• F. Hoffmann – La Roche Ltd (Switzerland),
• Avexis, Inc. (The U.S),
• Novartis AG (Switzerland),
• Cytokinetics, Inc. (The U.S),
• Pfizer Inc. (The U.S),
• Boehringer Ingelheim International GmbH (Germany),
• Regeneron Pharmaceuticals, Inc (The U.S), and
• Abbott (The U.S).

Scope of the Report

The research study analyzes the global Spinal Muscular Atrophy Medicine industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Spinal Muscular Atrophy Medicine Market Report

1. What was the Spinal Muscular Atrophy Medicine Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Spinal Muscular Atrophy Medicine Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Spinal Muscular Atrophy Medicine Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.